foxo4-dri senolytic peptide study 2017 cell

foxo4-dri senolytic peptide study 2017 cell alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice The disordered p53 transactivation domain

Name: foxo4-dri senolytic peptide study 2017 cell alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice The disordered p53 transactivation domain
Brand: astonvaughan.co.uk
SKU: 28929762538
Price: 28.06 USD
Availability: InStock
Rating: 4.1287 (30 reviews)

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology

SKU: 28929762538 · From astonvaughan.co.uk

4.1

USD28.06 USD56.06

Pay in 4 interest-free payments of $7.01 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

HPLC Analysis Mass Spectrometry Confirmation Batch Traceability By purchasing this product you confirm that you are a qualified researcher and that this compound will be used exclusively for laboratory research purposes